Inflammatory breast cancer (IBC) is characterized by NF‐κB activation, which causes endoplasmic reticulum (ER) downregulation, overexpression of EGFR and ErbB2, and hyperactivation of MAPK.167. Here, ERBB2 is linked to inflammatory breast carcinoma.